To compare ropivacaine for spinal saddle block for two different sitting duration in fistula in ano surgery

Comparison of discharge readiness following fistula in ano surgery after one versus two minutes of saddle spinal block with hyperbaric ropivacaine

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/02/049410

Enrollment

Registered

2023-02-02

Start date

Unknown

Completion date

Unknown

Last updated

2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Ropivacaine: 1.6 ml of 0.75% ropivacaine heavy given between L3-L4 space once and comparison is made with sitting duration of one versus two minutes for saddle block effect in patients

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA physical status I and II of either sex. 2. Age between 18 to 65 years. 3. BMI 20 to 35 kg/m2 4. Scheduled for FIA surgery.

Exclusion criteria

Exclusion criteria: 1. Refusal by the patient. 2. Patients with coagulopathy and bleeding disorder. 3. Pre-existing local infection at the site of saddle block. 4. Pregnant or lactating women. 5. Contraindications or allergy to ropivacaine and diclofenac. 6. Patients having hemodynamic instability. 7. Patients having sensory or motor problems in the lower limbs. 8. Patients having pain in any area other than surgery site.

Design outcomes

Primary

Measure	Time frame
To compare the discharge readiness between 1 and 2 minutes of sitting after saddle block with hyperbaric ropivacaine in patients undergoing Fistula-in-Ano surgeryTimepoint: 0 min, 5 min, 10 min, 15 min, 30 min, 60 min, 2 hours, 4 hours, 6 hours, 12 hours, 24 hours	—

Secondary

Measure	Time frame
1. To assess any complications like hypotension, urinary retention, postoperative nausea/vomiting, headache and backache. 2. To assess visual analogue scale (VAS) at rest and on movement. 3. To calculate mean analgesic consumption of diclofenac up to 24 hours. 4. To evaluate surgeon satisfaction score.Timepoint: 0 min, 5 min, 10 min, 15 min, 30 min, 60 min, 2 hours, 4 hours, 6 hours, 12 hours, 24 hours	—

Measure

Time frame

1. To assess any complications like hypotension, urinary retention, postoperative nausea/vomiting, headache and backache. 2. To assess visual analogue scale (VAS) at rest and on movement. 3. To calculate mean analgesic consumption of diclofenac up to 24 hours. 4. To evaluate surgeon satisfaction score.Timepoint: 0 min, 5 min, 10 min, 15 min, 30 min, 60 min, 2 hours, 4 hours, 6 hours, 12 hours, 24 hours

—

Countries

India

Contacts

Public ContactDr Deepak Thapa

Government Medical College and Hospital, Sector 32, Chandigarh

dpkthapa@gmail.com9646121524

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026